Particle.news
Download on the App Store

Tom Brady Says His Dog Is a Clone of Late Family Pet as Colossal Buys Viagen

The disclosure coincided with Colossal Biosciences' purchase of Viagen to expand cloning services for pet owners and conservation.

Overview

  • Brady said his pit bull mix, Junie, was created from blood drawn from his late dog, Lua, before her death in December 2023, calling it a second chance for his family.
  • The news was released through Colossal Biosciences, the Dallas biotech firm that worked on the cloning and in which Brady is an investor.
  • Colossal announced the acquisition of Viagen Pets and Equine, a long‑running pet‑cloning company known for work with celebrity clients and licenses linked to the Roslin Institute’s Dolly technology.
  • Reported pricing places dog cloning in the $50,000 to $85,000 range, reflecting a growing commercial market for genetic banking and replication services.
  • Colossal’s broader de‑extinction ambitions remain contentious, with its 2024 claim of producing dire wolf pups disputed by conservation groups including the IUCN, even as supporters tout potential conservation benefits.